摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2E)-3-(4-fluorophenyl)-N-[4-(pyrrolidin-1-ylsulfonyl)phenyl]prop-2-enamide

中文名称
——
中文别名
——
英文名称
(2E)-3-(4-fluorophenyl)-N-[4-(pyrrolidin-1-ylsulfonyl)phenyl]prop-2-enamide
英文别名
(E)-3-(4-fluorophenyl)-N-(4-pyrrolidin-1-ylsulfonylphenyl)prop-2-enamide
(2E)-3-(4-fluorophenyl)-N-[4-(pyrrolidin-1-ylsulfonyl)phenyl]prop-2-enamide化学式
CAS
——
化学式
C19H19FN2O3S
mdl
——
分子量
374.4
InChiKey
BSUQZUDEZDBXSY-LFYBBSHMSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    26
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.21
  • 拓扑面积:
    74.9
  • 氢给体数:
    1
  • 氢受体数:
    5

文献信息

  • Compounds and methods for the treatment of microbial infections
    申请人:The University of Hong Kong
    公开号:US10471045B2
    公开(公告)日:2019-11-12
    Provided herein are compounds, derivatives thereof, composition comprising one or more of said compounds and derivatives, and methods for prevention and/or treatment of microbial infections and/or related diseases or conditions. The present compounds and/or derivatives thereof can be represented by Formula (I): The present methods include administering to a subject an effective amount of one or more compounds of Formula (I). In one embodiment, said microbial infections are bacterial infections. More specifically, said bacterial infections are staphylococcal infections.
    本文提供了化合物、其衍生物、包含一种或多种所述化合物和衍生物的组合物,以及预防和/或治疗微生物感染和/或相关疾病或病症的方法。本化合物和/或其衍生物可由式 (I) 表示: 本方法包括向受试者施用有效量的一种或多种式(I)化合物。在一个实施方案中,所述微生物感染是细菌感染。更具体地说,所述细菌感染是葡萄球菌感染。
  • COMPOUNDS AND METHODS FOR THE TREATMENT OF MICROBIAL INFECTIONS
    申请人:The University of Hong Kong
    公开号:US20190022060A1
    公开(公告)日:2019-01-24
    Provided herein are compounds, derivatives thereof, composition comprising one or more of said compounds and derivatives, and methods for prevention and/or treatment of microbial infections and/or related diseases or conditions. The present compounds and/or derivatives thereof can be represented by Formula (I): The present methods include administering to a subject an effective amount of one or more compounds of Formula (I). In one embodiment, said microbial infections are bacterial infections. More specifically, said bacterial infections are staphylococcal infections.
查看更多